# Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIV

> **NCT00001119** · NA · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 288 (—)

## Conditions studied

- HIV Infections

## Interventions

- **BIOLOGICAL:** Tetanus Toxoid Vaccine
- **DRUG:** Indinavir sulfate
- **DRUG:** Lamivudine/Zidovudine
- **DRUG:** Ritonavir
- **DRUG:** Abacavir sulfate
- **DRUG:** Amprenavir
- **DRUG:** Efavirenz
- **BIOLOGICAL:** Hepatitis B Vaccine (Recombinant)
- **DRUG:** Lamivudine
- **DRUG:** Zidovudine

## Key facts

- **NCT ID:** NCT00001119
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-10
- **Primary completion:** 2004-06
- **Final completion:** —
- **Target enrollment:** 288 (—)
- **Last updated:** 2011-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001119

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001119, "Effects on the Immune System of Anti-HIV Drugs in Patients Recently Infected With HIV". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00001119. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*